399 related articles for article (PubMed ID: 26378517)
1. Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Harrer A; Wipfler P; Pilz G; Oppermann K; Haschke-Becher E; Afazel S; Kraus J; Trinka E; Sellner J
Int J Mol Sci; 2015 Sep; 16(9):21832-45. PubMed ID: 26378517
[TBL] [Abstract][Full Text] [Related]
2. T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Ricklin ME; Lorscheider J; Waschbisch A; Paroz C; Mehta SK; Pierson DL; Kuhle J; Fischer-Barnicol B; Sprenger T; Lindberg RL; Kappos L; Derfuss T
Neurology; 2013 Jul; 81(2):174-81. PubMed ID: 23700335
[TBL] [Abstract][Full Text] [Related]
3. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients.
Matko S; Akgün K; Tonn T; Ziemssen T; Odendahl M
Mult Scler Relat Disord; 2020 Feb; 38():101859. PubMed ID: 31855843
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster laryngitis in a patient treated with fingolimod.
Hagiya H; Yoshida H; Shimizu M; Motooka D; Nakamura S; Iida T; Yamamoto N; Akeda Y; Tomono K
J Infect Chemother; 2016 Dec; 22(12):830-832. PubMed ID: 27553068
[TBL] [Abstract][Full Text] [Related]
5. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
Arvin AM; Wolinsky JS; Kappos L; Morris MI; Reder AT; Tornatore C; Gershon A; Gershon M; Levin MJ; Bezuidenhoudt M; Putzki N
JAMA Neurol; 2015 Jan; 72(1):31-9. PubMed ID: 25419615
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Song ZY; Yamasaki R; Kawano Y; Sato S; Masaki K; Yoshimura S; Matsuse D; Murai H; Matsushita T; Kira J
PLoS One; 2014; 10(4):e0124923. PubMed ID: 25919001
[TBL] [Abstract][Full Text] [Related]
8. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
[TBL] [Abstract][Full Text] [Related]
9. The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
Aramideh Khouy R; Karampoor S; Keyvani H; Bokharaei-Salim F; Monavari SH; Taghinezhad S; Etemadifar M; Esghaei M
J Neuroimmunol; 2019 Mar; 328():94-97. PubMed ID: 30610966
[TBL] [Abstract][Full Text] [Related]
10. [The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod].
Tanaka M
Rinsho Shinkeigaku; 2016 Apr; 56(4):270-2. PubMed ID: 27010095
[TBL] [Abstract][Full Text] [Related]
11. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons.
Pomerantz HS; Xu X; White J; Sunil TS; Deiss RG; Ganesan A; Agan BK; Okulicz JF
AIDS Res Ther; 2018 Dec; 15(1):25. PubMed ID: 30537970
[TBL] [Abstract][Full Text] [Related]
12. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
13. High-Resolution Expression Profiling of Peripheral Blood CD8
Roch L; Hecker M; Friess J; Angerer IC; Koczan D; Fitzner B; Schröder I; Flechtner K; Thiesen HJ; Meister S; Winkelmann A; Zettl UK
Mol Neurobiol; 2017 Sep; 54(7):5511-5525. PubMed ID: 27631876
[TBL] [Abstract][Full Text] [Related]
14. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
[TBL] [Abstract][Full Text] [Related]
16. Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series.
Signoriello E; Bonavita S; Sinisi L; Russo CV; Maniscalco GT; Casertano S; Saccà F; Lanzillo R; Morra VB; Lus G
Mult Scler Relat Disord; 2020 May; 40():101963. PubMed ID: 31986424
[TBL] [Abstract][Full Text] [Related]
17. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
18. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
[TBL] [Abstract][Full Text] [Related]
19. Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.
Arnold N; Meyer C; Engelmann F; Messaoudi I
J Neurovirol; 2017 Aug; 23(4):520-538. PubMed ID: 28321697
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
